Synthesis, Antibacterial Studies and Crystal Structures of Tridentate Schiff Base Ligand and It’s Cobalt(III) Complex
- 1.4k Downloads
- 8 Citations
Abstract
The crystal structures of 4-[(2-hydroxyphenyl)imino]-2-pentanone (H2hpac, 1) and its cobalt(III) complex [CoIII(hpac)py3]+·PF6 − (2) have been determined by X-ray diffraction. The ligand 1 crystallizes in orthorhombic chiral P212121 space group, with a = 8.8405(4) Å, b = 10.5349(8) Å, c = 11.2292)7( Å), and the complex 2—in the centrosymmetric monoclinic P2/n space group, with a = 16.496(5) Å, b = 10.171(2) Å, c = 16.646(5) Å, and β = 95.53(3)°. In the ligand molecule quite strong intramolecular hydrogen bond closes six-membered ring. The bond length pattern within this ring suggests the significant conjugation and the structure might be therefore regarded as the intermediate between keto-enamine and zwitterionic forms, and the intramolecular hydrogen bond falls into category of resonance-assisted hydrogen bonds. In turn, intermolecular O–H···O hydrogen bonds connect the molecules of the ligand into infinite chains along [100] direction. In the complex, the Co(III) ion is hexa-coordinated, by two oxygen and one nitrogen atoms of the doubly-deprotonated ligand 1 and by three nitrogen atoms from three pyridine ligands. The coordination polyhedron is close to a slightly distorted octahedron. The in vitro antimicrobial activity of the Schiff base ligand and its corresponding complex have been tested against human pathogenic bacterias such as Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa and Escherichia coli.
Graphical Abstract
Keywords
Schiff base Tridentate ligands Co complex Hydrogen bonds Biological activityResults and Discussion
The preparation of the complex with tautomeric forms of the Schiff base
Cobalt(III) complexes derived from symmetrical and nonsymmetrical Schiff bases have drawn considerable attention in the past for their important biological applications. A number of model complexes with cobalt(II) and cobalt(III) have been prepared with particular emphasis on the reactivity of the metal ions in the transmethylation reaction and on the reversible absorption of molecular oxygen [12, 13, 14, 15, 16, 17, 18]. As a continuation of our studies on Schiff bases [19] we have performed the preparation and characterization of [CoIII(hpac)py3]PF6 (hereafter referred to as 2). The spectral properties of the complex were investigated by FT-IR, UV–Vis, and 1HNMR spectra. The X-ray crystal structures of 2 and of the ligand 1 have been determined. The antibacterial activities of both the Schiff base ligand 1 and it’s complex 2 against Bacillus subtilis (Gram-positive), Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative) and Pseudomonas aeruginosa (Gram-negative) have also been evaluated.
Synthesis and Characterization
In the preparation of the cobalt(III) complex, a vigorous stream of air was passed through a solution of CoII(hpac) in methanol to which excess pyridine was gradually added. The air oxidation was continued for a period of 3 h during which the color changed from red to green. A solution of KPF6 in methanol was then added to the resulting green solution and stirred for 5 min. Dark red crystals of the complex were obtained in good yield (60 %).
The IR spectra of the free Schiff base ligand and corresponding complex show several bands in the 400–4,000 cm−1 region. The NH stretching frequency of the free ligand, observed at 3,460 cm–1, is due to the internal hydrogen bonding vibration (O−···H–N+). The bands related with the C=O and O–H bonds, present in the free ligand, are not observed in the spectra of the complex. The stretching vibration of PF6 − anion is observed at 841 cm−1 [20]. The electronic absorption spectrum of the complex, measured in chloroform, shows a true maximum band at 575 nm. Relatively low value of ε (181 M−1 cm−1) of this band suggests that it can be assigned to the d–d transition.
1HNMR spectrum of [CoL(py)3]PF6 in CDCl3
Molecular Structures
Selected geometrical parameters (Å, °) with esd’s in parentheses
| Ligand 1 | Complex 2 | ||
|---|---|---|---|
| C1–O2 | 1.3589(18) | C41–O42 | 1.353(4) |
| C7–N8 | 1.4155(18) | C47–N48 | 1.441(4) |
| N8–C9 | 1.3402(17) | N48–C49 | 1.331(5) |
| C9–C11 | 1.377(2) | C49–C51 | 1.415(5) |
| C11–C12 | 1.407(2) | C51–C52 | 1.379(4) |
| C12–O13 | 1.2592(17) | C52–O53 | 1.308(3) |
| Co1–O42 | 1.916(2) | ||
| Co1–N48 | 1.907(3) | ||
| Co1–O53 | 1.898(2) | ||
| Co1–N11 | 1.988(3) | ||
| Co1–N21 | 1.982(3) | ||
| Co1–N31 | 1.976(3) | ||
| C7–N8–C9 | 130.88(12) | C47–N48–C49 | 127.8(3) |
| N8–C9–C11 | 120.41(13) | N48–C49–C51 | 121.3(3) |
| C9–C11–C12 | 124.87(13) | C49–C51–C52 | 127.0(3) |
| C11–C12–O13 | 122.40(13) | C51–C52–O53 | 125.0(3) |
| C6–C7–N8–C9 | 37.2(2) | C46–C47–N48–C49 | −26.2(5) |
| C7–N8–C9–C11 | 177.23(14) | C47–N48–C49–C51 | 172.9(3) |
| C7–N8–C9–C10 | −0.9(2) | C47–N48–C49–C50 | −6.8(5) |
| N8–C9–C11–C12 | −3.4(2) | N48–C49–C51–C52 | −10.2(5) |
| C9–C11–C12–O13 | 2.7(2) | C49–C51–C52–O53 | 10.7(5) |
| C9–C11–C12–C14 | −176.07(16) | C49–C51–C52–C54 | −165.5(3) |
Perspective view of the ligand, H2hpac (1) together with labeling scheme [17]; the displacement ellipsoids are drawn at 50 % probability level, hydrogen atoms are shown as spheres of arbitrary radii. Intramolecular hydrogen bond is drawn as dashed line
Hydrogen bond data for 1 (Å, °)
| D | H | A | D–H | H···A | D···A | D–H···A |
|---|---|---|---|---|---|---|
| O2 | H2 | O13i | 0.92(2) | 1.73(2) | 2.6440(14) | 174(2) |
| N8 | H8 | O13 | 0.905(19) | 1.883(19) | 2.6434(15) | 140.3(15) |
| C14 | H14A | CgAii | 0.96 | 2.80 | 3.724(3) | 162 |
| C15 | H15 | F3Aiii | 0.95 | 2.60 | 3.386(5) | 140 |
| C15 | H15 | F1Aiii | 0.95 | 2.64 | 3.568(4) | 166 |
| C24 | H24 | F6Aiv | 0.95 | 2.64 | 3.513(4) | 152 |
| C25 | H25 | F2Aiv | 0.95 | 2.43 | 3.204(4) | 138 |
| C26 | H26 | F1Av | 0.95 | 2.49 | 3.397(4) | 161 |
| C33 | H33 | O42vi | 0.95 | 2.60 | 3.534(4) | 168 |
| C34 | H34 | F6A | 0.95 | 2.57 | 3.354(4) | 140 |
| C35 | H35 | F3A | 0.95 | 2.44 | 3.311(4) | 152 |
| C35 | H35 | F3Avii | 0.95 | 2.57 | 3.355(4) | 140 |
| C36 | H36 | F5Avii | 0.95 | 2.57 | 3.449(4) | 153 |
| C44 | H44 | F6Aviii | 0.95 | 2.50 | 3.356(4) | 150 |
| C50 | H50C | F4Avii | 0.98 | 2.64 | 3.523(4) | 151 |
| C54 | H54C | F1Av | 0.98 | 2.53 | 3.451(4) | 157 |
The crystal packing of H2hpac as seen along [001] direction [6]. Hydrogen bonds are shown as dashed lines
Perspective view of the complex, [CoL(py)3]+PF6 − with labelling scheme [17]. The displacement ellipsoids are drawn at 50 % probability level, hydrogen atoms are shown as spheres of arbitrary radii
The crystal packing of [CoL(py)3]PF6 as seen along [001] direction [33]. The dashed lines denote short contacts (cf. text)
Biological Properties
Zones of inhibition of chemical compounds against pathogenic bacteria
| Zones of inhibitiona (mm) | ||
|---|---|---|
| H2hpac (1) | [CoIII(H2hpac)py3]PF6 (2) | |
| Bacillus subtilis | 8 | 11 |
| Staphylococcus aureus | 14 | 12 |
| Escherichia coli | 6 | 8 |
| Pseudomonas aeruginosa | – | – |
Experimental
Reagents and Measurements
All other chemicals were commercial reagent grade and used as received from Aldrich and Merck. Elemental analyses were performed by using a Perkin–Elmer 2400II CHNS–O elemental analyzer. UV–Vis spectra were recorded on a JASCO V-570 spectrophotometer. Infrared spectra (KBr pellets) were obtained on a FT-IR JASCO 680 plus spectrophotometer. 1HNMR spectra were obtained on a Bruker Avance DRX 500 (500 MHz) spectrometer. Proton chemical shifts are reported in ppm relative to an internal standard of Me4Si.
Synthesis of Schiff Base Ligand 1
The Schiff base ligand, 4-[(2-hydroxyphenyl)imino]-2-pentanone (H2hpac), was prepared as described in the literature [6]. The single crystals suitable for X-ray data collection were obtained by slow evaporation of the ethanol solution (after 2 days). The crystals were filtered off, washed with a small amount of cold methanol and dried under vacuum.
Synthesis of Complex 2
To a stirring solution of Co(CH3COO)2·4H2O (0.125 g, 0.5 mmol) in methanol (25 ml) was added an equimolar of H2hpac (0.095 g, 0.5 mmol). The pink solution turned brown immediately upon the formation of [CoII(hpac)] complex. To this solution was added 4 mmol of pyridine, and air was bubbled through the reaction mixture for about 3 h. 0.5 mmol of KPF6 was then added to the resulting green brown solution and stirred for 5 min. The single crystals suitable for X-ray data collection were obtained by slow evaporation of the methanol solution after 3 days. The crystals were filtered off,washed with a small amount of cold methanol and dried under vacuum. FT-IR (KBr, cm−1): 1,574 (C=N), 841 (s, PF6) UV–Vis: λmax (nm), ε (L mol−1 cm−1) (CH3CN) 196 (79,000), 275 (70,000), 336 (24,600), 586 (181). 1HNMR (500 MHz, CDCl3, δ, ppm): 2.38 (s, 3H, Ha), 2.58 (s, 3H, Hb), 5.32 (s, 1H, Hc), 6.45–7.19 (4H, phenyl ring proton) 7.26–8.70 (15H, pyridine C–H proton). Anal. Calcd. For C26H26N4O2PF6Co: C, 49.54; H, 4.16; N, 8.89; Found: C, 49.05; H, 4.10; N, 8.68 %.
X-ray Crystallography
Crystal data collection and structure refinement
| 1 | 2 | |
|---|---|---|
| Molecular formula | C11H13NO2 | C26H26CoN4O2·PF6 |
| Formula weight | 191.22 | 630.41 |
| Crystal system | Orthorhombic | Monoclinic |
| Space group | P212121 | P2/n |
| a (Å) | 8.8405(4) | 16.496(5) |
| b (Å) | 10.5349(8) | 10.171(2) |
| c (Å) | 11.2292(7) | 16.646(5) |
| β (°) | 90 | 95.53(3) |
| V (Å3) | 1045.82(11) | 2779.9(13) |
| Z | 4 | 4 |
| D x (g cm−3) | 1.214 | 1.506 |
| F(000) | 408 | 1,288 |
| μ(mm−1) | 0.68 | 0.75 |
| θ range (°) | 6.4–73.3 | 3.2–28.8 |
| hkl range | −10 ≤ h ≤ 8 | −20 ≤ h ≤ 21 |
| −13 ≤ k ≤ 13 | −13 ≤ k ≤ 13 | |
| –13 ≤ l ≤ 12 | −20 ≤ l ≤ 22 | |
| Reflections | ||
| Collected | 2,741 | 10,210 |
| Unique (R int) | 1804 (0.017) | 10,210 |
| With I > 2σ(I) | 1,725 | 4,173 |
| Number of parameters | 158 | 362 |
| Weighting scheme | ||
| A | 0.0507 | 0.0050 |
| B | 0.0572 | 0 |
| Final R index [I > 2σ(I)] | R 1 = 0.0303, wR 2 = 0.0828 | R 1 = 0.0468, wR 2 = 0.0783 |
| R index [all data] | R 1 = 0.0316, wR 2 = 0.0843 | R 1 = 0.1241, wR 2 = 0.0910 |
| Goodness-of-fit on F 2 | 1.05 | 0.64 |
| Max/min ∆ρ (e Å−3) | 0.11/− 0.10 | 0.60/−0.60 |
CCDC 860226 (1) and 860227 (2) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif or e-mail: deposit@ccdc.cam.ac.uk.
Antibacterial Activity
The antimicrobial activity of synthesized compounds was evaluated by disk diffusion assay [31] and twofold dilution method [32]. The Gram negative and Gram positive standard strains, namely Bacillus subtilis (B. subtilis; PTCC No: 1023; ATCC 6633); Staphylococcus aureus (S. aureus; PTCC No: 1431; ATCC 25923), Escherichia coli (E. coli; PTCC No: 1399; ATCC 25922), and Pseudomonas aeruginosa (P. aeruginosa; PTCC No: 1430; ATCC 27853) were purchased from Iranian Research Organization for Science and Technology (IROST). All bacteria were grown on Muller–Hinton Agar plates (37 °C, 24 h) and the zones of inhibition were measured after 24 h. Each organism was tested in duplicate on different days to measure the reproducibility of the test. Ampicillin, chloramphenicol, kanamycin, and penicillin were purchased from PadtanTeb Company (Iran) and used as reference antibacterial agents.
Conclusion
A new cobalt(III) complex with a tridentate Schiff base ligand and pyridine has been synthesized and characterized by spectroscopic measurements. Structures were determined by X-ray diffraction. The cobalt ion is coordinated by one N and two O atoms from a Schiff base ligand and by the N atoms of three pyridine molecules to form a distorted octahedral geometry. The intramolecular ionic hydrogen bonding is observed in the enolic form of the ligand.
Notes
Acknowledgments
We thank Semnan University for supporting this study.
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
References
- 1.Genovese S, Epifano F, Marcotullio MC, Pelucchini C, Curini M (2011) Tetrahedron Lett 52:3474CrossRefGoogle Scholar
- 2.Bellec N, Massue J, Roisnel T, Lorcy D (2007) Inorg Chem Commun 10:1172CrossRefGoogle Scholar
- 3.Huq F, Skapski AC (1974) J Cryst Mol Struct 4:411CrossRefGoogle Scholar
- 4.Von Chrzanowski LS, Lutz M, Spek Al (2007) Acta Crystallogr Sec C Cryst Struct Commun 63:377CrossRefGoogle Scholar
- 5.Laskar IR, Hsu S-F, Chen T-M (2006) Polyhedron 25:1167CrossRefGoogle Scholar
- 6.Zhang QL, Zhu BX (2008) J Coord Chem 61:2340CrossRefGoogle Scholar
- 7.Dominiak PM, Grech E, Barr G, Teat S, Mallinson P, Wozniak K (2003) Chem Eur J 9:963CrossRefGoogle Scholar
- 8.Filarowski A, Koll A (1998) Vib Spectrosc 17:123CrossRefGoogle Scholar
- 9.Krygowski TM, Wozniak K, Anulewicz R, Pawlak D, Kolodziejski W, Grech E, Szady A (1997) J Phys Chem A101:9399CrossRefGoogle Scholar
- 10.Bertolasi V, Gilli P, Ferretti V, Gilli G (1991) J Am Chem Soc 113:4917CrossRefGoogle Scholar
- 11.Özkar S, Ülkü D, Yıldırım LT, Biricikc N, Gümgüm B (2004) J Mol Struct 688:207CrossRefGoogle Scholar
- 12.Mondal N, Dey DK, Mitra S, Malik KMA (2000) Polyhedron 19:2707CrossRefGoogle Scholar
- 13.Parashar RK, Sharma RC, Kumar A, Mohan G (1988) Inorg Chim Acta 151:201CrossRefGoogle Scholar
- 14.Brückner S, Calligaris M, Nardin G, Randaccio L (1968) Inorg Chim Acta 4:386Google Scholar
- 15.Chen H, Han D, Yan H, Tang W, Yang Y, Wang H (1993) Polyhedron 12:1097CrossRefGoogle Scholar
- 16.Costes JP, Cros G, Darbieu MH, Laurent JP (1982) Inorg Chim Acta 60:111CrossRefGoogle Scholar
- 17.Böttcher A, Takeuchi T, Hardcastle KI, Meade TJ, Gray HB, Wikel DC, Kapon M, Dori Z (1997) Inorg Chem 36:2498CrossRefGoogle Scholar
- 18.Clearfield A, Gopal R, Kline RJ, Sipski M, Urban LO (1978) J Coord Chem 7:163CrossRefGoogle Scholar
- 19.Salehi M, Dutkiewicz G, Kubicki M (2010) Acta Cryst E66:o1590Google Scholar
- 20.Amirnasr M, Langer V, Rasouli N, Salehi M, Meghdadi S (2005) Can J Chem 83:2073CrossRefGoogle Scholar
- 21.Gilli P, Bertolasi V, Ferretti V, Gilli G (1994) J Am Chem Soc 116:909CrossRefGoogle Scholar
- 22.Wozniak K, He H, Klinowski J, Jones W, Dziembowska T, Grech E (1995) J Chem Soc, Faraday Trans 91:77CrossRefGoogle Scholar
- 23.Gilli G, Bellucci F, Ferretti V, Bertolasi V (1989) J Am Chem Soc 111:1023CrossRefGoogle Scholar
- 24.Schenk KJ, Meghdadi S, Amirnasr M, Habibi MH, Amiri A, Salehi M, Kashi A (2007) Polyhedron 26:5448CrossRefGoogle Scholar
- 25.Nejo AA, Kolawole GA, Nejo AO (2010) J Coord Chem 63:4398CrossRefGoogle Scholar
- 26.Mishra A, Kaushik NK, Verma AK, Gupta R (2008) Eur J Med Chem 43:2189CrossRefGoogle Scholar
- 27.Agilent Technologies (2009) CRYSALIS PRO, Version 1.171.33.36Google Scholar
- 28.Farrugia LJ (1997) J Appl Crystallogr 30:565CrossRefGoogle Scholar
- 29.Altomare A, Cascarano G, Giacovazzo C, Gualardi A (1993) J Appl Crystallogr 26:343CrossRefGoogle Scholar
- 30.Sheldrick GM (2008) Acta Cryst A64:112Google Scholar
- 31.Bauer AW, Kirby WM, Sheris JC, Turck M (1966) Am J Clin Pathol 45:493Google Scholar
- 32.European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases (2000) Clin Microbiol Infect 6:509CrossRefGoogle Scholar
- 33.Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, Rodriguez-Monge L, Taylor R, van de Streek J, Wood PA (2008) J Appl Crystallogr 41:466CrossRefGoogle Scholar






